Search
Degarelix acetate is a synthetic GnRH antagonist. It reduces the release of gonadotropins and testosterone through reversible binding to the pituitary gland's GnRH receptors, thereby exerting anti-prostate cancer effects.
Degarelix acetate is a gonadotropin-releasing hormone (GnRH) receptor inhibitor that reversibly inhibits pituitary GnRH receptors to reduce gonadotropin release and subsequently inhibit testosterone release. Degarelix acetate delays the growth and progression of prostate cancer by suppressing testosterone, which is essential for the continued growth of prostate cancer. Hormone therapy for prostate cancer to lower testosterone concentrations initially causes a spike in testosterone concentrations, and this initial stimulation of the hormone receptor temporarily promotes tumor growth rather than suppresses it, while degarelix acetate does not.
Product Name | Degarelix Acetate |
Apperance | White powder |
EINECS | N/A |
MF | C82H103ClN18O16 |
MW | 1632.28 |
Impurity | ≤0.5% |
Assay | ≥98.0% |
Product parameters | |
Cas number: | 214766-78-6 |
Appearance: | White powder |
Purity: | 98% min |
Package details: | 1g/bottle;1kg/bag or as you require |
Brand: | Fortunachem |
Guaranteed the purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: